Logo image
Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer's Disease
Journal article   Open access   Peer reviewed

Gaussian Mixture Models and Model Selection for [18F] Fluorodeoxyglucose Positron Emission Tomography Classification in Alzheimer's Disease

Rui Li, Robert Perneczky, Igor Yakushev, Stefan Förster, Alexander Kurz, Alexander Drzezga and Stefan Kramer
PloS one, Vol.10(4), pp.e0122731-e0122731
2014
DOI: 10.1371/journal.pone.0122731
PMCID: PMC4412726
PMID: 25919662
url
https://doi.org/10.1371/journal.pone.0122731View
Published (Version of record) Open Access

Abstract

We present a method to discover discriminative brain metabolism patterns in [18F] fluorodeoxyglucose positron emission tomography (PET) scans, facilitating the clinical diagnosis of Alzheimer's disease. In the work, the term "pattern" stands for a certain brain region that characterizes a target group of patients and can be used for a classification as well as interpretation purposes. Thus, it can be understood as a so-called "region of interest (ROI)". In the literature, an ROI is often found by a given brain atlas that defines a number of brain regions, which corresponds to an anatomical approach. The present work introduces a semi-data-driven approach that is based on learning the characteristics of the given data, given some prior anatomical knowledge. A Gaussian Mixture Model (GMM) and model selection are combined to return a clustering of voxels that may serve for the definition of ROIs. Experiments on both an in-house dataset and data of the Alzheimer's Disease Neuroimaging Initiative (ADNI) suggest that the proposed approach arrives at a better diagnosis than a merely anatomical approach or conventional statistical hypothesis testing.
Models, Theoretical Fluorodeoxyglucose F18 - pharmacokinetics Brain - diagnostic imaging Radiopharmaceuticals - pharmacokinetics Humans Male Positron-Emission Tomography - methods Normal Distribution Alzheimer Disease - pathology Sensitivity and Specificity Aged, 80 and over Brain - pathology Female Aged Alzheimer Disease - diagnostic imaging

Details

Metrics

Logo image